CONVERGE BIOTECH Trademark

Trademark Overview

On Wednesday, June 7, 2006, a trademark application was filed for CONVERGE BIOTECH with the United States Patent and Trademark Office. The USPTO has given the CONVERGE BIOTECH trademark a serial number of 78903138. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 29, 2010. This trademark is owned by Converge Biotech, Inc.. The CONVERGE BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Medical devices, namely, surgical implants comprising living tissue that function to produce and release therapeutic factors for autoimmune diseases where cells are not functional, namely, diabetes, lupus, hemophilia, rheumatoid arthritis, Parkinson's disease, Huntington's disease, liver diseases, myasthenia gravis, hypoparathyroidism, hypoadrenalism, osteoporosis, and cardiovascular disease
converge biotech

General Information

Serial Number78903138
Word MarkCONVERGE BIOTECH
Filing DateWednesday, June 7, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 29, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 7, 2007

Trademark Statements

Disclaimer with Predetermined Text"BIOTECH"
Goods and ServicesMedical devices, namely, surgical implants comprising living tissue that function to produce and release therapeutic factors for autoimmune diseases where cells are not functional, namely, diabetes, lupus, hemophilia, rheumatoid arthritis, Parkinson's disease, Huntington's disease, liver diseases, myasthenia gravis, hypoparathyroidism, hypoadrenalism, osteoporosis, and cardiovascular disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 13, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameConverge Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33136
Party NameConverge Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33136

Trademark Events

Event DateEvent Description
Monday, November 29, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 29, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, May 7, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 6, 2010EXTENSION 5 GRANTED
Friday, April 30, 2010EXTENSION 5 FILED
Friday, April 30, 2010TEAS EXTENSION RECEIVED
Saturday, October 31, 2009EXTENSION 4 GRANTED
Thursday, October 22, 2009EXTENSION 4 FILED
Thursday, October 22, 2009TEAS EXTENSION RECEIVED
Thursday, August 27, 2009EXTENSION 3 GRANTED
Thursday, April 30, 2009EXTENSION 3 FILED
Wednesday, August 26, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 30, 2009EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 30, 2009PETITION TO REVIVE-GRANTED
Thursday, July 30, 2009TEAS PETITION TO REVIVE RECEIVED
Monday, June 1, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 1, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 30, 2008EXTENSION 2 GRANTED
Thursday, October 30, 2008EXTENSION 2 FILED
Thursday, October 30, 2008TEAS EXTENSION RECEIVED
Thursday, February 21, 2008EXTENSION 1 GRANTED
Thursday, February 21, 2008EXTENSION 1 FILED
Thursday, February 21, 2008TEAS EXTENSION RECEIVED
Tuesday, October 30, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 7, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2007NOTICE OF PUBLICATION
Tuesday, July 3, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 3, 2007ASSIGNED TO LIE
Tuesday, May 29, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, May 29, 2007EXAMINERS AMENDMENT E-MAILED
Tuesday, May 29, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 29, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 29, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 29, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, May 29, 2007EXAMINERS AMENDMENT E-MAILED
Tuesday, May 29, 2007EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 8, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 7, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 8, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 7, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 8, 2006NON-FINAL ACTION E-MAILED
Wednesday, November 8, 2006NON-FINAL ACTION WRITTEN
Wednesday, November 8, 2006ASSIGNED TO EXAMINER
Tuesday, June 13, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

biotech converge disease namely diseases parkinson lupus arthritis rheumatoid huntington hemophilia liver